Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam (Q39353584)

11 September 2017

Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam (English)

1 reference

11 September 2017

0 references

0 references

0 references

0 references

0 references

Plasmodium vivax malaria

1 reference

Giao T Phan

1

1 reference

11 September 2017

Peter J de Vries

2

1 reference

11 September 2017

Binh Q Tran

3

1 reference

11 September 2017

Hung Q Le

4

1 reference

11 September 2017

Nam V Nguyen

5

1 reference

11 September 2017

Thang V Nguyen

6

1 reference

11 September 2017

Siem H Heisterkamp

7

1 reference

11 September 2017

Piet A Kager

8

1 reference

11 September 2017

1 October 2002

1 reference

Tropical Medicine and International Health

11 September 2017

1 reference

11 September 2017

7

1 reference

11 September 2017

858-864

1 reference

11 September 2017

10

1 reference

Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine

11 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Survey of resistance to chloroquine of falciparum and vivax malaria in Palawan, The Philippines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Survey of resistance to chloroquine by Plasmodium vivax in Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Chloroquine sensitivity of Plasmodium vivax in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Treatment of vivax malaria on the western border of Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Development of resistance to chloroquine by Plasmodium vivax in Myanmar

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Vivax malaria resistant to treatment and prophylaxis with chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Therapeutic responses to different antimalarial drugs in vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Plasmodium vivax resistance to chloroquine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Whole blood concentrations of chloroquine and desethylchloroquine during and after treatment of adult patients infected with Plasmodium vivax, P. ovale or P. malariae

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

A mixed infection of vivax and falciparum malaria apparently resistant to 4-aminoquinoline: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Chloroquine-resistant Plasmodium vivax in Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Estimating the Dimension of a Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Clinical response and susceptibility in vitro of Plasmodium vivax to the standard regimen of chloroquine in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Failure of chloroquine treatment for malaria in the highlands of Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Combinations of artemisinin and quinine for uncomplicated falciparum malaria: efficacy and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Comparison of artemether and chloroquine for severe malaria in Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Treatment of Malaria in Vietnam with Oral Artemisinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

Assessing drug sensitivity of Plasmodium vivax to halofantrine or choroquine in southern, central Vietnam using an extended 28-day in vivo test and polymerase chain reaction genotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00948.X

10.1046/J.1365-3156.2002.00948.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference